Critical pathways in microbial virulence

被引:32
作者
Curtis, MA [1 ]
Slaney, JM [1 ]
Aduse-Opoku, J [1 ]
机构
[1] MRC, Mol Pathogenesis Grp, Ctr Infect Dis, Inst Cell & Mol Sci,Barts & London Queen Marys Sc, London E1 2AT, England
关键词
gene expression; pathogenicity; virulence;
D O I
10.1111/j.1600-051X.2005.00817.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The virulence of a microbe represents a combination of complex factors including the agent's transmissibility and the severity of the disease associated with infection and is also significantly influenced by the susceptibility of the colonized host. Virulence factors may be defined as those products of the organism which are required to complete the various stages of the life cycle leading to pathology in the host. In this review, we examine some of the approaches which have been adopted in other fields of infectious disease in order to categorically identify virulence factors using a classical genetics approach with relevant models or human subjects. The absence of an accurate experimental model for periodontal disease means that our understanding of the microbial virulence determinants and pathways in this disease remains hypothetical and based largely on observations in vitro. However, factors which enable the organism to persist in spite of the elevated immune and inflammatory pressure at sites of disease are liable to be critical. Periodontal bacterial genomics is liable to make a significant impact on the field through an increased appreciation of the role of. gene acquisition and gene loss in the evolution of periodontal bacteria and of the consequences of strain variation in gene content on virulence potential.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 71 条
[1]  
Abe N, 1998, J BIOCHEM, V123, P305
[2]   Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis [J].
Banbula, A ;
Bugno, M ;
Kuster, A ;
Heinrich, PC ;
Travis, J ;
Potempa, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (03) :598-602
[3]   Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis [J].
Booth, V ;
Ashley, FP ;
Lehner, T .
INFECTION AND IMMUNITY, 1996, 64 (02) :422-427
[4]   REGULATION OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS LEUKOTOXIN EXPRESSION - ANALYSIS OF THE PROMOTER REGIONS OF LEUKOTOXIC AND MINIMALLY LEUKOTOXIC STRAINS [J].
BROGAN, JM ;
LALLY, ET ;
POULSEN, K ;
KILIAN, M ;
DEMUTH, DR .
INFECTION AND IMMUNITY, 1994, 62 (02) :501-508
[5]   LuxS-dependent quorum sensing in Porphyromonas gingivalis modulates protease and haemagglutinin activities but is not essential for virulence [J].
Burgess, NA ;
Kirke, DF ;
Williams, P ;
Winzer, K ;
Hardie, KR ;
Meyers, NL ;
Aduse-Opoku, J ;
Curtis, MA ;
Cámara, M .
MICROBIOLOGY-SGM, 2002, 148 :763-772
[6]   Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy [J].
Calkins, CC ;
Sameni, M ;
Koblinski, J ;
Sloane, BF ;
Moin, K .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1998, 46 (06) :745-751
[7]   Comparative whole-genome analysis of virulent and avirulent strains of Porphyromonas gingivalis [J].
Chen, T ;
Hosogi, Y ;
Nishikawa, K ;
Abbey, K ;
Fleischmann, RD ;
Walling, J ;
Duncan, MJ .
JOURNAL OF BACTERIOLOGY, 2004, 186 (16) :5473-5479
[8]   Summary: microbiological perspective [J].
Curtis, MA .
MOLECULAR IMMUNOLOGY, 2003, 40 (07) :477-479
[9]   Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic kgp protease inhibitor 2 [J].
Curtis, MA ;
Opoku, JA ;
Rangarajan, M ;
Gallagher, A ;
Sterne, JAC ;
Reid, CR ;
Evans, HEA ;
Samuelsson, B .
INFECTION AND IMMUNITY, 2002, 70 (12) :6968-6975
[10]   Cysteine proteases of Porphyromonas gingivalis [J].
Curtis, MA ;
Aduse-Opoku, J ;
Rangarajan, M .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2001, 12 (03) :192-216